Rodríguez DY, Bustillo SEE, García RMF, Navia RI

Language: Spanish
References: 15
Page:
PDF size: 261.76 Kb.

ABSTRACT

Background: The glycemic control of the hospitalized diabetic patient is a priority which guarantees positive results in hospitable indicators. Objective: To evaluate the use of lab studies which determine the glycemic control of the hospitalized diabetic patient. Methodology: A descriptive investigation was carried out which comprised two periods of 2009 at Camilo Cienfuegos General Hospital. The study population was the amount of 170 diabetic patients: 157 discharged alive and 13 dead. Results: The use of lab studies addressed to determine the levels glycemia and cetonuria at the moment of admission were indicated ion less than the half od the patients. The follow up of intrahospitable hyperglycemia had difficulties not only in the ordinary wards but in the progressive cares as well. In most of the cases the glycemic grade control was not determined. Conclusions: The disglycemia diagnosis and follow up in the hospitalized diabetic patient in the periods evaluated was not optimum.

REFERENCES

1. Clement S, Braithwaite SS, Magee MF, Ahmann A, Smith EP, Schafer RG, et al.; American Diabetes Association; Diabetes in Hospitals Writing Committee. Management of diabetes and hyperglycemia in hospitals. Diabetes Care 2004;27:553–91. Available from: http://care.diabetesjournals.org/content/27/2/553.long

2. Van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, et al.; Intensive insulin therapy in the critically ill patients. N Engl J Med 2001; 345:1359–67. Available from: http://www.umm.edu/nursing/docs/intensive_insulin_therapy.pdf

3. Malmberg K, Norhammar A, Wedel H, Rydén L. Glycometabolic state at admission: important risk marker of mortality in conventionally treated patients with diabetes mellitus and acute myocardial infarction: long-term results from the Diabetes and Insulin-Glucose Infusion in Acute Myocardial Infarction (DIGAMI) study. Circulation 1999; 99:2626–32. Available from: http://circ.ahajournals.org/content/99/20/2626.full

4. Finfer S, Chittock DR, Su SY, Blair D, Foster D, Dhingra V, et al.; NICESUGAR Study Investigators. Intensive versus conventional glucose control in critically ill patients. N Engl JMed 2009; 360:1283–97. Available from: http://www.ncbi.nlm.nih.gov/m/pubmed/19318384/

5. Krinsley JS, Grover A. Severe hypoglycemia in critically ill patients: risk factors and outcomes. Crit Care Med 2007;35:2262–7. Available from: http://journals.lww.com/ccmjournal/Abstract/2007/10000/Severe_hypoglycemia_in_critically_i ll_patients_.4.aspx

6. Etie S. Moghissi, Mary T. Korytkowski, Monica DiNardo, Daniel Einhorn, Richard Hellman, Irl B. Hirsch, et al.; American Association of Clinical Endocrinologists; American Diabetes Association. American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. Diabetes Care 2009;32:1119– 31 Available from: http://care.diabetesjournals.org/content/32/6/1119.short

7. Wiener RS, Wiener DC, Larson RJ. Benefits and risks of tight glucose control in critically ill adults: a meta-analysis. JAMA 2008;300:933–944. Available from: http://jama.jamanetwork.com/article.aspx?articleid=182432

8. Kripalani S, LeFevre F, Phillips CO, Williams MV, Basaviah P, Baker DW. Deficits in Communication and Information Transfer Between Hospital-Based and Primary Care Physicians: Implications for Patient Safety and Continuity of Care. JAMA. 2007;297(8):831-41. Available from: http://jama.jamanetwork.com/article.aspx?articleid=205790

9. Standards of Medical Care in Diabetes 2012. Diabetes Care, Volume 35, Supplement 1, January 2012. Available from: http://care.diabetesjournals.org/content/35/Supplement_1/S11.full?sid=32d82637-262a-4f79- b81d-710e86aa3baa

10. Gisela Del Carmen De La Rosa, Jorge Hernando Donado, Alvaro Humberto Restrepo, Alvaro Mauricio Quintero, Luis Gabriel González, Nora Elena Saldarriaga,, et al: Strict glycaemic control in patients hospitalised in a mixed medical and surgical intensive care unit: a randomised clinical trial. Crit Care 2008; 12R120. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2592751/

11. Garber AJ, Moghissi ES, Bransome ED Jr, Clark NG, Clement S, Cobin RH, et al. American College of Endocrinology position statement on inpatient diabetes and metabolic control. Endocr Pract 2004; 10: 77-82. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2681039/

12. Umpierrez GE, Isaacs SD, Bazargan N, You X, Thaler LM, Kitabchi AE: Hyperglycemia: an independent marker of inhospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab 87:978 –982, 2002. Available from: http://jcem.endojournals.org/content/87/3/978.full

13. AACE Diabetes Mellitus Guidelines, Endocr Pract. 2007;13(Suppl 1) 2007. Available from: http://aace.metapress.com/content/a205210114r6l833/fulltext.pdf

14. Cryer PE: Hypoglycemia: the limiting factor in the glycemic management of type I and type II diabetes. Diabetologia 45:937–948, 2002. Available from: http://www.springerlink.com/content/xby30p2fwxt8mjv3/fulltext.html

15. Greci LS, Kailasam M, Malkani S, Katz DL, Hulinsky I, Ahmadi R, et al: Utility of HbA1c levels for diabetes case finding in hospitalized patients with hyperglycemia. Diabetes Care 26:1064–1068, 2003. Available from: http://care.diabetesjournals.org/content/26/4/1064.short